EPISODE · Aug 23, 2026 · 19 MIN
mRNA株の次の主戦場は「がん治療」へ!モデルナ成功で始まる勝者と敗者の選別
from 米国株投資で幸せ作り · host beikoku-stock
モデルナのmRNAがんワクチン第3相試験成功で、mRNA株の主戦場は感染症からがん治療へ。ビオンテックなど関連企業の戦略、感染症市場縮小のリスク、M&Aの可能性から、今後の勝者と敗者を分析します。https://beikoku-stock.com/2026/08/24/mrna-stocks-cancer-treatment-moderna-future/
Embed this episode
Ready to play
mRNA株の次の主戦場は「がん治療」へ!モデルナ成功で始まる勝者と敗者の選別
0:00
19:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 米国株投資で幸せ作り?
This episode is 19 minutes long.
When was this 米国株投資で幸せ作り episode published?
This episode was published on August 23, 2026.
Can I download this 米国株投資で幸せ作り episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!